论文部分内容阅读
目的:研究雷贝拉唑治疗幽门螺杆菌相关性胃溃疡的临床价值。方法:选取2011年2月-2014年2月东莞市人民医院收治的98例幽门螺杆菌相关性胃溃疡患者,随机分为对照组与观察组各49例。两组均在给予甲硝唑与阿莫西林治疗的基础上,对照组加服奥美拉唑联合治疗,观察组加服雷贝拉唑联合治疗。结果:治疗后观察组临床病症:腹痛、腹胀、嗳气、反酸的评分均明显低于对照组,观察组治疗总有效率明显高于对照组。结论:雷贝拉唑治疗幽门螺杆菌相关性胃溃疡比奥美拉唑效果更为显著。
Objective: To study the clinical value of rabeprazole in the treatment of Helicobacter pylori associated gastric ulcer. Methods: A total of 98 patients with Helicobacter pylori-associated gastric ulcer admitted to Dongguan People’s Hospital from February 2011 to February 2014 were randomly divided into control group and observation group with 49 cases each. Both groups were given metronidazole and amoxicillin treatment, based on the control group plus omeprazole combination therapy, the observation group plus rabeprazole combination therapy. Results: After treatment, the clinical symptoms of the observation group were: abdominal pain, abdominal distension, belching, acid reflux scores were significantly lower than the control group, the observation group the total effective rate was significantly higher than the control group. Conclusion: Rabeprazole is more effective than omeprazole in the treatment of Helicobacter pylori associated gastric ulcer.